ConductScience.org, home

Paper690998

Metabolic fate of tolazamide in man and in the rat.

Thomas RC and 3 others. J Med Chem, 1978. Cited by 15 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Metabolic fate of tolazamide in man and in the rat. Papers, record 690998. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/690998

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metabolic fate of tolazamide in man and in the rat.
PubMed
Journal
J Med Chem
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.74
iCite
Revised in PubMed
2019-07-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thomas RCR C
2Duchamp DJD J
3Judy RWR W
4Ikeda GJG J

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
TolazamideMajor topic
Animals
Biotransformation
Blood Glucose
Chromatography, Paper
Chromatography, Thin Layer
Crystallization
Feces
Female
Humans
Hypoglycemic Agents
Intestinal Absorption
Male
Mass Spectrometry
Models, Molecular
Molecular Conformation
Rats
Tritium
X-Ray Diffraction

Source PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
41,106,059Alcohol dehydrogenase 4 and aldo-keto reductase 1A1 catalyze the oxidation of 4-hydroxytolbutamide, a metabolite of tolbutamide, in the human liver.Drug Metab Dispos2025https://conductscience.org/library/papers/41106059PubMed
32,331,223Metabolic-Hydroxy and Carboxy Functionalization of Alkyl Moieties in Drug Molecules: Prediction of Structure Influence and Pharmacologic Activity.Molecules2020https://conductscience.org/library/papers/32331223PubMed
8,853,933Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency.Clin Pharmacokinet1996https://conductscience.org/library/papers/8853933PubMed
7,030,708Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.Drugs1981https://conductscience.org/library/papers/7030708PubMed
3,301,149The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.Clin Pharmacokinet1987https://conductscience.org/library/papers/3301149PubMed
2,656,043Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.Clin Pharmacokinet1989https://conductscience.org/library/papers/2656043PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/690998

GET https://conductscience.org/api/papers/v1/690998/authors